General election 2024 in PP-163 Lahore 19 constituency of Punjab, the stage is set for a vibrant democratic exercise. With many candidates poised to enter the fray, the electoral landscape is abuzz ...
General election 2024 in PP-116 Faisalabad 19 constituency of Punjab, the stage is set for a vibrant democratic exercise. With many candidates poised to enter the fray, the electoral landscape is ...
Arcturus Therapeutics believes it’s “highly unlikely” it will lose the promised government funding for its bird flu mRNA ...
Arcturus Therapeutics Holdings Inc. (ARCT) reported a wider-than-expected loss for the fourth quarter of 2024, with earnings per share (EPS) of -$1.11, missing the forecast of -$0.19. The company ...
Arcturus received approval from the European Commission (EC) in February for KOSTAIVE, the world’s first approved sa-mRNA COVID-19 vaccine. The centralized marketing authorization of KOSTAIVE ...
Joseph Payne; President, Chief Executive Officer, Director; Arcturus Therapeutics Holdings Inc Andrew Sassine; Chief Financial Officer, Director; Arcturus Therapeutics Holdings Inc Padmanabh ...
Reports Q4 revenue $22.8M, consensus $44.64M. “We continue to progress our flagship rare disease programs and look forward to sharing ...
This amount will be credited against Arcturus' share of the COVID-19 development costs paid by CSL. When CSL recruits 40% of the total development costs of KOSTAIVE-19 program, Arcturus will begin ...
Analysts' ratings for Arcturus Therapeutics ARCT over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below offers a condensed view of their recent ratings ...
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...
With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. It can be easy to forget, or look away from ...